Premarket vibes: risk-off creeping in, Mag 7 mixed, AI names getting hit.
$META -1% heading into court Tuesday — states claim Facebook/Instagram were designed to hook kids. Classic.
$NVDA -1.9%, $TSLA -1.3%. Chipmakers + AI plays sliding as sentiment sours. Reminder: when everyone's long the same thing, any wobble hurts.
$BIDU -6% after missing revenue + burning cash for 5th straight quarter. Capex blowing out, iQiyi dragging. China tech still messy.
$ANF -2% after Raymond James downgrade post-rally. Classic "we like it less now that it's up" move.
$AMLX +26% on late-stage trial win for post-bariatric hypoglycemia drug. Biotech lottery ticket hits.
$HD +2% after solid earnings beat. Home improvement holding up despite high rates. People still fixing stuff.
$FN -9% after Datacom sales disappointed. When one segment misses, stock gets crushed.
$BBWI +3% on Citi upgrade to buy. Q2 beat + new product buzz.
$NCLH -2% downgraded by Mizuho on balance sheet concerns. Cruise lines = high leverage + macro sensitivity.
Macro setup: if risk-off sticks, watch how long AI momentum names can hold. Rotation into defensives or just cash?
Chart check: $NVDA approaching key support. Break below could trigger more pain across semis.
$META -1% heading into court Tuesday — states claim Facebook/Instagram were designed to hook kids. Classic.
$NVDA -1.9%, $TSLA -1.3%. Chipmakers + AI plays sliding as sentiment sours. Reminder: when everyone's long the same thing, any wobble hurts.
$BIDU -6% after missing revenue + burning cash for 5th straight quarter. Capex blowing out, iQiyi dragging. China tech still messy.
$ANF -2% after Raymond James downgrade post-rally. Classic "we like it less now that it's up" move.
$AMLX +26% on late-stage trial win for post-bariatric hypoglycemia drug. Biotech lottery ticket hits.
$HD +2% after solid earnings beat. Home improvement holding up despite high rates. People still fixing stuff.
$FN -9% after Datacom sales disappointed. When one segment misses, stock gets crushed.
$BBWI +3% on Citi upgrade to buy. Q2 beat + new product buzz.
$NCLH -2% downgraded by Mizuho on balance sheet concerns. Cruise lines = high leverage + macro sensitivity.
Macro setup: if risk-off sticks, watch how long AI momentum names can hold. Rotation into defensives or just cash?
Chart check: $NVDA approaching key support. Break below could trigger more pain across semis.